Global Stem Cells Group Chile CEO Enrique Testart will represent the biotech company at the in First CIMECA Convention in Panama City Feb. 17-19, 2016
MIAMI, Nov. 30, 2015—Global Stem Cells Group Chile CEO Eugene Testart, M.D., will join physicians, aesthetic practitioners
and aesthetics professionals from Central America and abroad for the first Iberoamerican Convention on Aesthetic Medicine, Cosmetology and Anti-Aging (CIMECA), to be held in Panama City, Panama Feb. 17-19, 2016. Testart will present and discuss new trends in anti-aging stem cell treatments, regenerative medicine and applications in aesthetic medicine.
Global Stem Cells Group subsidiary http://www.stemcelltraining.net will also implement a post-convention training certification course in stem cell techniques and technologies for physicians. The intensive, hands-on course in stem cell harvesting, isolation and re-integration, administered by by accredited and experienced specialists, and participants will receive det
ailed written protocols and a high-definition video of the procedure. Following course completion, each physician will receive certified stem cell specialist certification with with international validation for in-office stem cell procedures.
CIMECA will be the first event of its kind to be held in the Central America and Caribbean region to include medical and aesthetic professionals, businesses, and the Latin American public. The conference is designed to address the latest advances in aesthetic medicine, cosmetology, and anti-aging procedures from different perspectives.
The convention will feature keynote speeches, panel discussions and presentations on the latest trends, technologies and tools available to promote safe, profitable and ethical medical practices, together with the celebration of the first Aesthetic & Wellness Expo where the general public can participate.
CIMECA will address a wide variety of issues and treatments, including obesity, localized adiposity (the accumulation of fat tissue), cellulite, facial and body aesthetics, skincare. Keynote speeches and panel discussions will be accompanied by clinical case studies, new research in the field of aesthetics, new ideas, products and technologies that offer the latest developments and trends in aesthetic sciences.
CIMECA emerged on the initiative of a group of medical graduates of the Faculty of Medicine at the University of Panama and extension specialists in anti-aging medicine from the John F. Kennedy Argentine University and the Pinto Institute in Buenos Aires.
For more information, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
The first IIberoamerican Convention on Antiaging and Aesthetic Medicine Cosmetology (CIMECA), to be held Feb. 17-19 2016, is a unique event that will bring together physicians, medical practitioners, businesses beauty professionals and the public from Panama and throughout Central America. Participants will engage in conferences, keynote speeches, panel discussions and presentations on the latest trends, technologies and tools available to promote safe, profitable and ethical aesthetic medical practices.